Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > TNGX Tango Therapeutics > Detailed Quotes

TNGX Tango Therapeutics

Watchlist
6.600
+0.430+6.97%
Close  01/31 16:00 ET
6.6000.0000.00%
Pre Mkt Price 02/01 04:21 ET
High
6.620
Open
6.240
Turnover
2.25M
Low
6.060
Pre Close
6.170
Volume
350.69K
Market Cap
581.97M
P/E(TTM)
Loss
52wk High
9.990
Shares
88.18M
P/E(Static)
Loss
52wk Low
3.180
Float Cap
286.50M
Bid/Ask %
100.00%
Historical High
18.840
Shs Float
43.41M
Volume Ratio
1.86
Historical Low
3.180
Dividend TTM
--
Div Yield TTM
--
P/B
2.13
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.81%
Amplitude
9.08%
Avg Price
6.417
Lot Size
1
Float Cap
286.50M
Bid/Ask %
100.00%
Historical High
18.840
Shs Float
43.41M
Volume Ratio
1.86
Historical Low
3.180
Dividend TTM
--
P/B
2.13
Dividend LFY
--
Turnover Ratio
0.81%
Amplitude
9.08%
Avg Price
6.417
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Tango Therapeutics, Inc. operates as a biotechnology company, which engages in discovering and delivering precision cancer medicines. Its primary program is TNG908, a protein arginine methyl transferase 5 inhibitor that is being developed as a treatment for cancers with MTAP deletions. The company was founded by Alan Ashworth, William G. Kaelin, Jr., Jose Baselga, and Antoni Ribas in 2017 and is headquartered in Cambridge, MA.
CEO: Dr. Barbara L. Weber, M.D.
Market: NASDAQ
Listing Date: 08/11/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist